ClinicalTrials.gg
Status unknownNCT01190033Updated Mar 26, 2013

Study Of The Efficacy Of Neurolysis In Functional Recovery From Chronic Nonspecific Low Back Pain

An interventional study of Neurotome OFF and neurolysis in Low Back Pain, sponsored by University of Sao Paulo. Status unknown at 1 site in Brazil. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2013-03-26.

Sponsored by University of Sao Paulo · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2013), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This is a prospective, randomized, double-blind, placebo-controlled study. In an initial phase, 100 patients with chronic low back pain will be included in this study. The patients will be recruited through magazines and newspapers to take part in a screening for treatment of low back pain. This screening will involve the evaluation of data such as history and physical examination to classify the patient in the group of nonspecific low back pain, excluding patients with neurological alterations and the so-called Red-Flags.

Procedures After the initial screening the patients will undergo diagnostic blocks of the medial branch of lumbar vertebrae L2, L3, L4 , L5 and of the first sacral vertebra (S1) with lidocaine and control with distilled water. The patients that present more than 50% of pain improvement, evaluated by the Likert scale after 30 minutes will form the study group, while the patients that do not present pain improvement with lidocaine or that present pain improvement with distilled water will be excluded.

The medial branch block consists of the insertion of a 90mm, 25-gauge needle through the skin with radioscopic control up to the medial branch topography. Infusion of 1ml of 2% lidocaine should be performed in each medial branch of the abovementioned vertebrae. Control is executed in the same manner yet with infusion of 1ml of distilled water.

Through the use of the diagnostic block we will have 40 patients selected for the second phase of the study. Once defined the study group should be evaluated before the procedure through the Oswestry, Roland Morris, SF-36 and VAS questionnaires.

In the second phase of the study the patients will be randomized. The random division into two groups will be performed through a computerized program of random numbers. The randomization result will be kept in matt sealed envelopes to guarantee secrecy of the allocation. The neurolysis procedure will be carried out in the first group, consisting of 20 patients, and the placebo or sham procedure with the second group, also with 20 patients.

The neurolysis procedure will be carried out under sterile conditions, with the patient lying prone and with the neurotome insertion sites anesthetized with 2ml of 1% lidocaine. The neurotome (Smith \& Nephew - RF) will be used for the procedure. The neurotome is a radiofrequency apparatus mounted on a 10cm electrode type 22 needle with a 5mm exposure tip. The neurotome should be introduced percutaneously in a manner similar to that adopted in the medial branch block through radioscopic control. The temperature of the electrode after its placement in the correct position is then raised to 80 °C for 90 seconds. Two neurotomies should be performed for each facet, one proximally and the other distally, due to double innervation of each facet. In the patients of the placebo group the procedure will be the same only the temperature of the neurotome will not be raised. This will be performed in a blind manner, as before starting the procedure, the surgeon will show the assistant who turns the device on or not the envelope containing the patient's group (placebo or neurotomy), yet the surgeon will not be informed whether the device has been turned on or not, having to perform the procedure in the same manner in both groups.

The patients will then be reevaluated in the first month, 3 months after, 6 months after and 12 months after the procedure. The assessors will not be informed of the group to which the patient belongs, and the same scales performed in the preoperative period will be used here.

02

Conditions studied

  • Low Back Pain

Browse trials for

03

In context

Low Back Pain

2,875 studies on the registry are indexed under Low Back Pain; 484 are open to participants now.

This study's planned enrollment of 40 is below the median of 60 across 2,315 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

University of Sao Paulo is the lead sponsor of 1,030 studies on the registry; 92 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • clinical diagnosis of lumbar pain in a patient with age between 20 and 60 years.
  • present clinical complaints of low back pain for 3 months or more.
  • present pain of moderate to severe intensity: visual analogue scale (VAS) > 4.

Exclusion criteria

Exclusion Criteria:

  • patients that develop a profile compatible with specific low back pain during treatment.
  • patients that request their withdrawal from the study at any time.
  • patients that develop an allergy to the medication used.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Neurolysis

    In this intervention the neurotome will be connected

    Procedure: neurolysis

  • Placebo comparator
    Neurotome OFF

    neurotome not raised

    Device: Neurotome OFF

Interventions

  • DeviceNeurotome OFF

    In this intervention the neurotome will be unconnected.

  • Procedureneurolysis

    In this procedure the neurotome will be connected

06

What researchers measure

Primary outcomes

  1. Pain Evaluation

    Pain Scores on the Visual Analog Scale

    Time frame: The Patients will be evaluated 1 week before surgery

  2. Pain Evaluation

    Pain Scores on the Visual Analog Scale

    Time frame: The Patients will be evaluated one month after surgery

  3. Pain Evaluation

    Pain Scores on the Visual Analog Scale

    Time frame: The Patients will be evaluated three months after surgery

  4. Pain Evaluation

    Pain Scores on the Visual Analog Scale

    Time frame: The Patients will be evaluated six months after surgery

  5. Pain Evaluation

    Pain Scores on the Visual Analog Scale

    Time frame: The Patients will be evaluated one year after surgery

Secondary outcomes

  1. Disability evaluation

    The Oswestry disability questionnaire has been designed to give us information as to how the back or leg pain is affecting the ability to manage in everyday life.

    Time frame: The Patients will be evaluated one week before surgery

  2. Medial Block Improvement

    likert five-level scale is a scale for evaluation of improvement: * 0-30% improvement - no improvement * 30-50% improvement - moderate improvement * 50-80% improvement - good improvement * 80-100% improvement - no pain to evaluate the improvement after the medial branch block

    Time frame: one day after the medial branch block

  3. Health Status

    The Roland-Morris Questionnaire (RMQ) is a self-administered disability measure in which greater levels of disability are reflected by higher numbers on a 24-point scale.

    Time frame: The Patients will be evaluated one week before surgery

  4. Disability evaluation

    The Oswestry disability questionnaire has been designed to give us information as to how the back or leg pain is affecting the ability to manage in everyday life.

    Time frame: The Patients will be evaluated one month after surgery

  5. Disability evaluation

    The Oswestry disability questionnaire has been designed to give us information as to how the back or leg pain is affecting the ability to manage in everyday life.

    Time frame: The Patients will be evaluated three month after surgery

  6. Disability evaluation

    The Oswestry disability questionnaire has been designed to give us information as to how the back or leg pain is affecting the ability to manage in everyday life.

    Time frame: The Patients will be evaluated six month after surgery

  7. Disability evaluation

    The Oswestry disability questionnaire has been designed to give us information as to how the back or leg pain is affecting the ability to manage in everyday life.

    Time frame: The Patients will be evaluated one year after surgery

  8. Health Status

    The Roland-Morris Questionnaire (RMQ) is a self-administered disability measure in which greater levels of disability are reflected by higher numbers on a 24-point scale.

    Time frame: The Patients will be evaluated one month after surgery

  9. Health Status

    The Roland-Morris Questionnaire (RMQ) is a self-administered disability measure in which greater levels of disability are reflected by higher numbers on a 24-point scale.

    Time frame: The Patients will be evaluated three month after surgery

  10. Health Status

    The Roland-Morris Questionnaire (RMQ) is a self-administered disability measure in which greater levels of disability are reflected by higher numbers on a 24-point scale.

    Time frame: The Patients will be evaluated six month after surgery

  11. Health Status

    The Roland-Morris Questionnaire (RMQ) is a self-administered disability measure in which greater levels of disability are reflected by higher numbers on a 24-point scale.

    Time frame: The Patients will be evaluated one year after surgery

07

Study locations

1 of 1 sites recruiting
  • Institute of Orthopedics and Traumatology of the U.S.P
    São Paulo, São Paulo 05403-010, Brazil
    • Alexandre Cristante Fogaça · Contact · idr_77@hotmail.com · 30696912
    • Ivan Dias Rocha · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 26, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01190033
Responsible party
Alexandre F. Cristante (PhD., University of Sao Paulo) — Principal investigator
First posted
Aug 27, 2010
Start date
Aug 2010
Primary completion
Jul 2012
Completion
Jul 2013 (estimated)
Last update
Mar 26, 2013

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion